These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 34358176)

  • 1. Purpuric Skin Rash in a Patient Undergoing Pfizer-BioNTech COVID-19 Vaccination: Histological Evaluation and Perspectives.
    Cazzato G; Romita P; Foti C; Cimmino A; Colagrande A; Arezzo F; Sablone S; Barile A; Lettini T; Resta L; Ingravallo G
    Vaccines (Basel); 2021 Jul; 9(7):. PubMed ID: 34358176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
    Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathological Patterns of Cutaneous Adverse Reaction to Anti-SARS-CoV-2 Vaccines: The Integrative Role of Skin Biopsy.
    Cazzato G; Ambrogio F; Pisani MC; Colagrande A; Arezzo F; Cascardi E; Dellino M; Macorano E; Trilli I; Parente P; Lettini T; Romita P; Marzullo A; Ingravallo G; Foti C
    Vaccines (Basel); 2023 Feb; 11(2):. PubMed ID: 36851273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Rare Cutaneous Manifestation: Leukocytoclastic Vasculitis after Pfizer-BioNTech COVID-19 Vaccination.
    Serrano Gomez Y; Grella B; Wang H
    Case Rep Dermatol Med; 2022; 2022():4267930. PubMed ID: 36624889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse reactions to the first and second doses of Pfizer-BioNTech COVID-19 vaccine among healthcare workers.
    Maruyama A; Sawa T; Teramukai S; Katoh N
    J Infect Chemother; 2022 Jul; 28(7):934-942. PubMed ID: 35361536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Case of Purpura Annularis Telangiectodes of Majocchi after Anti-SARS-CoV-2 Pfizer-BioNTech Vaccine: Is There an Association?
    Ambrogio F; Laface C; Sbarra G; Filotico R; Ranieri G; Barlusconi C; De Marco A; Cazzato G; Bonamonte D; Romita P; Foti C
    Vaccines (Basel); 2022 Nov; 10(11):. PubMed ID: 36423067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant Severe Psoriasis and Bullous Pemphigoid Induced by COVID-19.
    Martora F; Battista T; Fabbrocini G; Megna M
    Trop Med Infect Dis; 2023 Feb; 8(2):. PubMed ID: 36828523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of IgG, IgA and IgM antibodies against SARS-CoV-2 spike protein S1 in convalescent and vaccinated patients with the Pfizer-BioNTech and CanSinoBio vaccines.
    Melgoza-González EA; Hinojosa-Trujillo D; Reséndiz-Sandoval M; Mata-Haro V; Hernández-Valenzuela S; García-Vega M; Bravo-Parra M; Arvizu-Flores AA; Valenzuela O; Velázquez E; Soto-Gaxiola A; Gómez-Meza MB; Pérez-Jacobo F; Villela L; Hernández J
    Transbound Emerg Dis; 2022 Jul; 69(4):e734-e745. PubMed ID: 34655457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous reactions after COVID-19 vaccination in Turkey: A multicenter study.
    Cebeci Kahraman F; Savaş Erdoğan S; Aktaş ND; Albayrak H; Türkmen D; Borlu M; Arıca DA; Demirbaş A; Akbayrak A; Polat Ekinci A; Gökçek GE; Çelik HA; Taşolar MK; An İ; Temiz SA; Hazinedar E; Ayhan E; Hızlı P; Solak EÖ; Kılıç A; Yılmaz E
    J Cosmet Dermatol; 2022 Sep; 21(9):3692-3703. PubMed ID: 35780311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Status migrainosus: a potential adverse reaction to Comirnaty (BNT162b2, BioNtech/Pfizer) COVID-19 vaccine-a case report.
    Consoli S; Dono F; Evangelista G; D'Apolito M; Travaglini D; Onofrj M; Bonanni L
    Neurol Sci; 2022 Feb; 43(2):767-770. PubMed ID: 34807361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative Analyses of IgA Antibody Response of Non-COVID-19 Infected People Over 60 Years Old Following CoronaVac and Pfizer-BioNTech COVID-19 Vaccination].
    Yürüker Ö; Yetkin O; Güvenir M
    Mikrobiyol Bul; 2023 Apr; 57(2):330-333. PubMed ID: 37067217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing Levels of Serum Anti-Spike S1-RBD IgG after 120 Days of the Pfizer-BioNTech-mRNA Second Dose Vaccination.
    Abdul-Wahab Kadhum A; Rushdi Abdullah A; Mujahid A
    Arch Razi Inst; 2023 Jun; 78(3):1071-1075. PubMed ID: 38028836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral erythema multiforme after Pfizer-BioNTech COVID-19 vaccination: a report of four cases.
    Petruzzi M; Galleggiante S; Messina S; Della Vella F
    BMC Oral Health; 2022 Mar; 22(1):90. PubMed ID: 35331228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 vaccination including 198 patients with history of severe anaphylactic reaction - own observations.
    Wentrys Ł; Stopyra L
    Przegl Epidemiol; 2021; 75(3):315-325. PubMed ID: 35170287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A definite case of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) induced by administration of the Pfizer/BioNTech BNT162b2 vaccine for SARS-CoV2.
    Schroeder JW; Gamba C; Toniato A; ; Rongioletti F
    Clin Dermatol; 2022; 40(5):591-594. PubMed ID: 35550918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of Homologous and Heterologous Vaccine Applications on SARS-CoV-2 Omicron Variant: Cohort of Manisa Celal Bayar University Healthcare Workers].
    Çiçek K; Özkaya Y; Eser E; Buran ZC; Öztürk Arıkan ZÖ; Akçalı S; Erbay Dündar P; Cengiz Özyurt B; Şenol Akar Ş; Özer D; Karadağ Yalçın F
    Mikrobiyol Bul; 2023 Apr; 57(2):238-251. PubMed ID: 37067208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccinating with a COVID-19 Vaccine: Experience of the Tertiary Allergology Center.
    Žilėnaitė E; Malinauskienė L; Černiauskas K; Griguola L; Linauskienė K; Kvedarienė V; Chomičienė A
    Acta Med Litu; 2022; 29(1):27-32. PubMed ID: 36061933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 Vaccination-Induced Rash: Does the Choice of Vaccine Matter?
    Zafar M; Ewnetu B; Ahmed S; Iqbal U; Whitehead M
    Cureus; 2021 Jun; 13(6):e15490. PubMed ID: 34268022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Humoral immunity against SARS-CoV-2 in workers of social health care centers of Castilla y León after vaccination with the BNT162b2 mRNA vaccine from Pfizer/Biontech.].
    Casas Fischer R
    Rev Esp Salud Publica; 2021 Oct; 95():. PubMed ID: 34690347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.